Literature DB >> 27325923

Practical applications of cardiovascular magnetic resonance.

F Alpendurada1, J Wong1, D J Pennell1.   

Abstract

Recent developments in magnetic resonance imaging have focused attention on evaluation of patients with cardiac disease. These improvements have been substantiated by a large and expanding body of clinical evidence, making cardiovascular magnetic resonance the imaging modality of choice in a wide variety of cardiovascular disorders. A brief review on the current applications of cardiovascular magnetic resonance is provided, with reference to some of the most relevant studies, statements and reviews published in this field.

Entities:  

Year:  2009        PMID： 27325923      PMCID： PMC4898490          DOI： 10.1136/ha.2009.000323

Source DB:  PubMed          Journal:  Heart Asia        ISSN： 1759-1104


  40 in total

1.  Assessment of myocardial viability with contrast-enhanced magnetic resonance imaging: comparison with positron emission tomography.

Authors:  Christoph Klein; Stephan G Nekolla; Frank M Bengel; Mitsuru Momose; Andrea Sammer; Felix Haas; Bernhard Schnackenburg; Wolfram Delius; Harald Mudra; Dieter Wolfram; Markus Schwaiger
Journal:  Circulation       Date:  2002-01-15       Impact factor: 29.690

Review 2.  CMR of ventricular function.

Authors:  Niall G Keenan; Dudley J Pennell
Journal:  Echocardiography       Date:  2007-02       Impact factor: 1.724

3.  Presentation, patterns of myocardial damage, and clinical course of viral myocarditis.

Authors:  Heiko Mahrholdt; Anja Wagner; Claudia C Deluigi; Eva Kispert; Stefan Hager; Gabriel Meinhardt; Holger Vogelsberg; Peter Fritz; Juergen Dippon; C-Thomas Bock; Karin Klingel; Reinhard Kandolf; Udo Sechtem
Journal:  Circulation       Date:  2006-10-02       Impact factor: 29.690

4.  Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy.

Authors:  Carsten Rickers; Norbert M Wilke; Michael Jerosch-Herold; Susan A Casey; Prasad Panse; Neeta Panse; Jochen Weil; Andrey G Zenovich; Barry J Maron
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

5.  Treatment of claustrophobia for cardiovascular magnetic resonance: use and effectiveness of mild sedation.

Authors:  J M Francis; D J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2000       Impact factor: 5.364

6.  Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocardiography.

Authors:  E Nagel; H B Lehmkuhl; W Bocksch; C Klein; U Vogel; E Frantz; A Ellmer; S Dreysse; E Fleck
Journal:  Circulation       Date:  1999-02-16       Impact factor: 29.690

7.  Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography.

Authors:  J C C Moon; N G Fisher; W J McKenna; D J Pennell
Journal:  Heart       Date:  2004-06       Impact factor: 5.994

8.  Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Martin S Maron; Camillo Autore; John R Lesser; Luigi Rega; Giancarlo Casolo; Marcello De Santis; Giovanni Quarta; Stefano Nistri; Franco Cecchi; Carol J Salton; James E Udelson; Warren J Manning; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2008-08-12       Impact factor: 24.094

9.  Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance.

Authors:  J A McCrohon; J C C Moon; S K Prasad; W J McKenna; C H Lorenz; A J S Coats; D J Pennell
Journal:  Circulation       Date:  2003-06-23       Impact factor: 29.690

10.  Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium.

Authors:  James C C Moon; Bhavesh Sachdev; Andrew G Elkington; William J McKenna; Atul Mehta; Dudley J Pennell; Philip J Leed; Perry M Elliott
Journal:  Eur Heart J       Date:  2003-12       Impact factor: 29.983
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.